JAKARTA The feud between Apple and Masimo, a global medical technology company, has finally officially ended. On Friday, October 25, a federal jury ruled that Masimo had violated Apple's patents.
There are several Masimo devices that are considered to have violated patents. Smart watch W1, smart watch Freedom, and Masimo's health module have violated the same patent, while Masimo's charger is considered to have violated other patents.
SEE ALSO:
The jury's decision also clearly stated that Apple should have won this patent feud. According to them, Masimo intentionally violated the patent.
On this decision, Apple must receive compensation of USD 250 (IDR 39 million), the minimum nominal compensation set by the local law. When compared to the amount of loss, this nominal is very small.
However, this compensation decision was not made by the jury. According to a Bloomberg Law report, Apple is asking for compensation in the lowest nominal because they just want to win over their patents.
"We are not here for money," John Desmarais, Apple's lawyer, told the jury in a closed argument. In accordance with the published ruling, the jury accepted Apple's request.
Earlier this year, Apple had the same problem as Masimo. The company is considered to have violated Masimo's patent by launching its pulse oxymmetry feature. As a result, Apple must stop selling devices that have this feature.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)